E Fund Management (HK)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
E Fund Management (HK)'s VRTX Position: Q2 2026 in Review
E Fund Management (HK) increased its Vertex Pharmaceuticals (VRTX) stake by 64% in Q2 2026, buying an estimated $255K and bringing the position to 1,483 shares worth $737K. The position accounts for 0.24% of the portfolio, ranked #70.
E Fund Management (HK) first reported a position in VRTX in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.88M in Q3 2022. 1,759 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- E Fund Management (HK) held 1,483 shares of Vertex Pharmaceuticals worth $737K as of Q2 2026.
- E Fund Management (HK) bought 576 Vertex Pharmaceuticals shares in Q2 2026, an estimated $255K.
- Vertex Pharmaceuticals made up 0.24% of E Fund Management (HK)'s portfolio in Q2 2026, its #70 holding.
- E Fund Management (HK) first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
- E Fund Management (HK)'s Vertex Pharmaceuticals position peaked at $1.88M in Q3 2022.
- 1,759 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.